US Stem Cell Products Market to Reach $3.0 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of US report on Stem Cells Research market. The US market for Stem Cell Products is projected to reach $3.0 billion by the year 2015. This is primarily driven by increasing number of physicians turning towards stem cell products to treat their patients, and acceptance of stem cell technology by patients for treating chronic diseases. Further, technological advancements in research areas and huge investments made by the governments also contribute to the market growth.

Stem Cells Research: A US Market Report

Stem cell therapy is an upcoming field and several pharmaceutical companies are showing considerable interest in this area. The emerging market for stem cell therapy is creating scope for further research in the field with huge investments. Stem cells represent one of the major research fields for drug discovery owing to their ability to generate any specialized cell of the body. Additionally, stem cells offer tremendous potential for treating various untreatable diseases.

Increasing number of research groups involved in stem cell-based activities and technological advancements in the research area are driving the demand for stem cells research in the United States, as stated by the new market research report on stem cells research market. Stem cell therapy can revolutionize treatment of various human disease forms. Several therapies involving adult stem cells are already in practice, especially transplants of bone marrow, which are used for treating leukemia and associated cancers of the blood and bone. However, stem cell sector, still in infancy stage, lacks fundamental knowledge on stem cell differentiation, despite considerable discoveries and advancement in the field. The governmental and ethical barriers are the major challenges ahead of stem cell research. The barriers are particularly more in embryonic stem cell research.

Key players profiled in the report include Advanced Cell Technology Inc., Atheists Inc., Biome Inc., Cryo-Cell International Inc., Cytori Therapeutics Inc., Edstrom Biosciences Inc., Geron Corporation, International Stem Cell Corporation, Neuralstem Inc., NeuroGeneration Inc., Osiris Therapeutics Inc., StemCells Inc., ThermoGenesis Corp and ViaCord LLC.

The report titled "Stem Cells Research: A US Market Report" announced by Global Industry Analysts, Inc., provides a review of market trends and developments, and recent industry activity. The study analyzes market data and analytics in terms of annual revenues.

For more details about this market research report, please visit -

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Email press(at)StrategyR(dot)com
Web Site


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website